Abstract
Children with autism often suffer from sleep disturbances, and compared to age-matched controls, have decreased melatonin levels, as indicated by urine levels of the primary melatonin metabolite, 6-sulfatoxymelatonin (6-SM). We therefore investigated the relationship between 6-SM levels and sleep architecture in children with autism spectrum disorders (ASD). Twenty-three children, aged 4-10 years, completed two nights of polysomnography and one overnight urine collection for measurement of urinary 6-SM excretion rate. Parents completed the Children's Sleep Habits Questionnaire. We found that higher urinary 6-SM excretion rates were associated with increased N3 sleep, decreased N2 sleep, and decreased daytime sleepiness. The results warrant further examination to examine the effects of supplemental melatonin on sleep architecture and daytime sleepiness.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 427-433 |
| Number of pages | 7 |
| Journal | Journal of Autism and Developmental Disorders |
| Volume | 41 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 1 2011 |
| Externally published | Yes |
Fingerprint
Keywords
- 6-SM
- 6-Sulfatoxymelatonin
- Children's sleep habits questionnaire
- Parental concerns questionnaire
- Polysomnography
- Sleep stages
ASJC Scopus subject areas
- Developmental and Educational Psychology
Cite this
Relation of melatonin to sleep architecture in children with autism. / Leu, Roberta M.; Beyderman, Liya; Botzolakis, Emmanuel J.; Surdyka, Kyla; Wang, Lily; Malow, Beth A.
In: Journal of Autism and Developmental Disorders, Vol. 41, No. 4, 01.04.2011, p. 427-433.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Relation of melatonin to sleep architecture in children with autism
AU - Leu, Roberta M.
AU - Beyderman, Liya
AU - Botzolakis, Emmanuel J.
AU - Surdyka, Kyla
AU - Wang, Lily
AU - Malow, Beth A.
PY - 2011/4/1
Y1 - 2011/4/1
N2 - Children with autism often suffer from sleep disturbances, and compared to age-matched controls, have decreased melatonin levels, as indicated by urine levels of the primary melatonin metabolite, 6-sulfatoxymelatonin (6-SM). We therefore investigated the relationship between 6-SM levels and sleep architecture in children with autism spectrum disorders (ASD). Twenty-three children, aged 4-10 years, completed two nights of polysomnography and one overnight urine collection for measurement of urinary 6-SM excretion rate. Parents completed the Children's Sleep Habits Questionnaire. We found that higher urinary 6-SM excretion rates were associated with increased N3 sleep, decreased N2 sleep, and decreased daytime sleepiness. The results warrant further examination to examine the effects of supplemental melatonin on sleep architecture and daytime sleepiness.
AB - Children with autism often suffer from sleep disturbances, and compared to age-matched controls, have decreased melatonin levels, as indicated by urine levels of the primary melatonin metabolite, 6-sulfatoxymelatonin (6-SM). We therefore investigated the relationship between 6-SM levels and sleep architecture in children with autism spectrum disorders (ASD). Twenty-three children, aged 4-10 years, completed two nights of polysomnography and one overnight urine collection for measurement of urinary 6-SM excretion rate. Parents completed the Children's Sleep Habits Questionnaire. We found that higher urinary 6-SM excretion rates were associated with increased N3 sleep, decreased N2 sleep, and decreased daytime sleepiness. The results warrant further examination to examine the effects of supplemental melatonin on sleep architecture and daytime sleepiness.
KW - 6-SM
KW - 6-Sulfatoxymelatonin
KW - Children's sleep habits questionnaire
KW - Parental concerns questionnaire
KW - Polysomnography
KW - Sleep stages
UR - http://www.scopus.com/inward/record.url?scp=79956048204&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79956048204&partnerID=8YFLogxK
U2 - 10.1007/s10803-010-1072-1
DO - 10.1007/s10803-010-1072-1
M3 - Article
C2 - 20683768
AN - SCOPUS:79956048204
VL - 41
SP - 427
EP - 433
JO - Journal of Autism and Developmental Disorders
JF - Journal of Autism and Developmental Disorders
SN - 0162-3257
IS - 4
ER -